British Technology Group (BTG), is an international healthcare company focused on interventional medicine. In late November 2018, Boston Scientific Corporation (BSC) announced that it would be acquiring BTG plc for USD 4.2 billion. Boston Scientific manufactures medical devices with interventional medicine specialities. In this report, we analyze a total of 1,487 currently active published patent applications in BTG’s portfolio, and take a closer look at the portfolios of BTG and BSC.

Download the Report
First Name

Last Name


We would also like to contact you via e-mail with information and updates about Relecura. Please uncheck the box below if you do not wish to be contacted.

Receiving the report is contingent upon checking the box. None of the data fields you have entered above will be stored by us, unless you both check the box below and click on “Submit”.

I would like to receive information about Relecura via email.

Reload Image

*To download the report, enable JavaScript if it is disabled in your browser.